Rare and common variants in KIF15 contribute to genetic risk of idiopathic pulmonary fibrosis
File(s)KIF15_AJRCCM_10.20.2021_no figures_clean.docx (151.68 KB)
Accepted version
Author(s)
Type
Journal Article
Abstract
RATIONALE: Genetic studies of Idiopathic Pulmonary Fibrosis (IPF) have improved our understanding of this disease, but not all causal loci have been identified. OBJECTIVE: To identify genes enriched with rare deleterious variants in IPF and familial pulmonary fibrosis. METHODS: We performed gene burden analysis of whole exome data, tested single variants for disease association, conducted KIF15 functional studies, and examined human lung single cell RNA sequencing data. MEASUREMENT AND MAIN RESULTS: Gene burden analysis of 1,725 cases and 23,509 controls identified heterozygous rare deleterious variants in KIF15, a kinesin involved in spindle separation during mitosis, and three telomere-related genes (TERT, RTEL1, PARN). KIF15 was implicated in autosomal dominant models of rare deleterious variants (OR 4.9 [95%CI 2.7, 8.8] P=2.55x10-7) and rare protein-truncating variants (OR 7.6 [3.3, 17.1], P=8.12x10-7). Meta-analysis of the discovery and replication cohorts, including 2,966 cases and 29,817 controls, confirm the involvement of KIF15, plus the three telomere-related genes. A common variant within a KIF15 intron (rs74341405, OR 1.6 [1.4, 1.9], P=5.63x10-10) is associated with IPF risk, confirming a prior report. Lymphoblastoid cells from individuals heterozygous for the common variant have decreased KIF15 and reduced rates of cell growth. Cell proliferation is dependent on KIF15 in the presence of an inhibitor of Eg5/KIF11, which has partially redundant function. KIF15 is expressed specifically in replicating human lung cells, and shows diminished expression in replicating epithelial cells of IPF patients. CONCLUSIONS: Both rare deleterious variants and common variants in KIF15 link a non-telomerase pathway of cell proliferation with IPF susceptibility.
Date Issued
2022-07-01
Date Acceptance
2022-04-13
Citation
American Journal of Respiratory and Critical Care Medicine, 2022, 206 (1)
ISSN
1073-449X
Publisher
American Thoracic Society
Journal / Book Title
American Journal of Respiratory and Critical Care Medicine
Volume
206
Issue
1
Copyright Statement
©2022 by the American Thoracic Society
Sponsor
Action for Pulmonary Fibrosis
Identifier
https://www.ncbi.nlm.nih.gov/pubmed/35417304
Grant Number
n/a
Subjects
Cell proliferation
Genetics
IPF
KIF15
spindle
Publication Status
Published
Coverage Spatial
United States
Date Publish Online
2022-04-13